Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > Sorry folks - been preoccupied elsewhere

<< Previous

Bullboard Posts

Next >>

Comment by MrMugsyon Feb 12, 2024 8:08pm

192 Views

Post# 35876601

RE:RE:Sorry folks - been preoccupied elsewhere

I believe the ENDO portfolio has been stalled by government investigation. That's taking some time to play out. I also see ENDO trying again to move the sale forward. As per Samira ... this could take a while to play out.

Yes - Amal is on The Board at ATE ... and ... Samira before her ... and ... Goodman before her.

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale